<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for cutaneous-post-benefit 1440014015275 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_INTERFERON_GAMMA_RESPONSE'>HALLMARK_INTERFERON_GAMMA_RESPONSE</a></td><td><a href='HALLMARK_INTERFERON_GAMMA_RESPONSE.html'>Details ...</a></td><td>171</td><td>0.71</td><td>3.41</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2080</td><td>tags=64%, list=15%, signal=75%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_INTERFERON_ALPHA_RESPONSE'>HALLMARK_INTERFERON_ALPHA_RESPONSE</a></td><td><a href='HALLMARK_INTERFERON_ALPHA_RESPONSE.html'>Details ...</a></td><td>86</td><td>0.74</td><td>3.18</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2274</td><td>tags=70%, list=16%, signal=83%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_ALLOGRAFT_REJECTION'>HALLMARK_ALLOGRAFT_REJECTION</a></td><td><a href='HALLMARK_ALLOGRAFT_REJECTION.html'>Details ...</a></td><td>137</td><td>0.66</td><td>3.07</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1856</td><td>tags=53%, list=13%, signal=61%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_IL6_JAK_STAT3_SIGNALING'>HALLMARK_IL6_JAK_STAT3_SIGNALING</a></td><td><a href='HALLMARK_IL6_JAK_STAT3_SIGNALING.html'>Details ...</a></td><td>65</td><td>0.66</td><td>2.71</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1913</td><td>tags=54%, list=14%, signal=62%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_COMPLEMENT'>HALLMARK_COMPLEMENT</a></td><td><a href='HALLMARK_COMPLEMENT.html'>Details ...</a></td><td>141</td><td>0.52</td><td>2.47</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1917</td><td>tags=40%, list=14%, signal=46%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_INFLAMMATORY_RESPONSE'>HALLMARK_INFLAMMATORY_RESPONSE</a></td><td><a href='HALLMARK_INFLAMMATORY_RESPONSE.html'>Details ...</a></td><td>133</td><td>0.44</td><td>2.09</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2266</td><td>tags=37%, list=16%, signal=44%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_KRAS_SIGNALING_DN'>HALLMARK_KRAS_SIGNALING_DN</a></td><td><a href='HALLMARK_KRAS_SIGNALING_DN.html'>Details ...</a></td><td>54</td><td>0.39</td><td>1.57</td><td>0.028</td><td>0.028</td><td>0.216</td><td>3383</td><td>tags=39%, list=24%, signal=51%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_COAGULATION'>HALLMARK_COAGULATION</a></td><td><a href='HALLMARK_COAGULATION.html'>Details ...</a></td><td>84</td><td>0.35</td><td>1.51</td><td>0.015</td><td>0.038</td><td>0.319</td><td>1709</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_IL2_STAT5_SIGNALING'>HALLMARK_IL2_STAT5_SIGNALING</a></td><td><a href='HALLMARK_IL2_STAT5_SIGNALING.html'>Details ...</a></td><td>158</td><td>0.32</td><td>1.50</td><td>0.004</td><td>0.037</td><td>0.344</td><td>1662</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY'>HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY</a></td><td><a href='HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY.html'>Details ...</a></td><td>44</td><td>0.39</td><td>1.49</td><td>0.034</td><td>0.036</td><td>0.358</td><td>3062</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_KRAS_SIGNALING_UP'>HALLMARK_KRAS_SIGNALING_UP</a></td><td><a href='HALLMARK_KRAS_SIGNALING_UP.html'>Details ...</a></td><td>141</td><td>0.32</td><td>1.47</td><td>0.006</td><td>0.039</td><td>0.404</td><td>923</td><td>tags=19%, list=7%, signal=20%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_APOPTOSIS'>HALLMARK_APOPTOSIS</a></td><td><a href='HALLMARK_APOPTOSIS.html'>Details ...</a></td><td>142</td><td>0.31</td><td>1.43</td><td>0.009</td><td>0.048</td><td>0.509</td><td>3017</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_PI3K_AKT_MTOR_SIGNALING'>HALLMARK_PI3K_AKT_MTOR_SIGNALING</a></td><td><a href='HALLMARK_PI3K_AKT_MTOR_SIGNALING.html'>Details ...</a></td><td>86</td><td>0.30</td><td>1.29</td><td>0.076</td><td>0.135</td><td>0.895</td><td>2730</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_UV_RESPONSE_UP'>HALLMARK_UV_RESPONSE_UP</a></td><td><a href='HALLMARK_UV_RESPONSE_UP.html'>Details ...</a></td><td>126</td><td>0.26</td><td>1.20</td><td>0.122</td><td>0.246</td><td>0.989</td><td>2478</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_XENOBIOTIC_METABOLISM'>HALLMARK_XENOBIOTIC_METABOLISM</a></td><td><a href='HALLMARK_XENOBIOTIC_METABOLISM.html'>Details ...</a></td><td>132</td><td>0.25</td><td>1.17</td><td>0.162</td><td>0.273</td><td>0.995</td><td>1776</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_APICAL_SURFACE'>HALLMARK_APICAL_SURFACE</a></td><td><a href='HALLMARK_APICAL_SURFACE.html'>Details ...</a></td><td>29</td><td>0.32</td><td>1.08</td><td>0.351</td><td>0.434</td><td>0.999</td><td>615</td><td>tags=14%, list=4%, signal=14%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_ESTROGEN_RESPONSE_LATE'>HALLMARK_ESTROGEN_RESPONSE_LATE</a></td><td><a href='HALLMARK_ESTROGEN_RESPONSE_LATE.html'>Details ...</a></td><td>133</td><td>0.20</td><td>0.91</td><td>0.702</td><td>0.879</td><td>1.000</td><td>2628</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>18</td><td><a href='http://cancerimmunity.org/peptide/overexpressed/'>CANCER_IMMUNITY_ANTIGENS_OVEREXPRESSED_IN_TUMORS</a></td><td><a href='CANCER_IMMUNITY_ANTIGENS_OVEREXPRESSED_IN_TUMORS.html'>Details ...</a></td><td>27</td><td>0.26</td><td>0.88</td><td>0.622</td><td>0.921</td><td>1.000</td><td>1018</td><td>tags=15%, list=7%, signal=16%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_ADIPOGENESIS'>HALLMARK_ADIPOGENESIS</a></td><td><a href='HALLMARK_ADIPOGENESIS.html'>Details ...</a></td><td>177</td><td>0.18</td><td>0.85</td><td>0.827</td><td>0.946</td><td>1.000</td><td>2017</td><td>tags=16%, list=14%, signal=18%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_PANCREAS_BETA_CELLS'>HALLMARK_PANCREAS_BETA_CELLS</a></td><td><a href='HALLMARK_PANCREAS_BETA_CELLS.html'>Details ...</a></td><td>10</td><td>0.33</td><td>0.83</td><td>0.674</td><td>0.944</td><td>1.000</td><td>656</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>21</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_APICAL_JUNCTION'>HALLMARK_APICAL_JUNCTION</a></td><td><a href='HALLMARK_APICAL_JUNCTION.html'>Details ...</a></td><td>136</td><td>0.16</td><td>0.75</td><td>0.967</td><td>1.000</td><td>1.000</td><td>3295</td><td>tags=26%, list=24%, signal=34%</td></tr><tr><td class='lessen'>22</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_WNT_BETA_CATENIN_SIGNALING'>HALLMARK_WNT_BETA_CATENIN_SIGNALING</a></td><td><a href='HALLMARK_WNT_BETA_CATENIN_SIGNALING.html'>Details ...</a></td><td>35</td><td>0.20</td><td>0.74</td><td>0.853</td><td>0.981</td><td>1.000</td><td>2697</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>23</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_E2F_TARGETS'>HALLMARK_E2F_TARGETS</a></td><td><a href='HALLMARK_E2F_TARGETS.html'>Details ...</a></td><td>193</td><td>0.14</td><td>0.70</td><td>0.996</td><td>0.968</td><td>1.000</td><td>4311</td><td>tags=33%, list=31%, signal=47%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>cutaneous-post-benefit (4 samples)<b>&nbsp<a href='gsea_report_for_cutaneous-post-benefit_1440014015275.tsv'>[plain text format]</a></caption></table></div><br></body></html>
